首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1547507

全球荷尔蒙避孕药市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Hormonal Contraceptives Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球荷尔蒙避孕药市场需求预计将从 2023 年的 233.5 亿美元达到近 358.5 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 4.88%。

荷尔蒙避孕药是常用的节育方法。它含有少量人造雌激素和黄体酮。荷尔蒙避孕药的主要目的是破坏正常的荷尔蒙平衡，抑制排卵并防止怀孕。荷尔蒙避孕药有多种形式，分别是阴道环、荷尔蒙释放避孕线圈、皮肤贴片和避孕药。它也用于治疗多囊性卵巢症候群（PCOS），安全可靠。荷尔蒙避孕药分为复方荷尔蒙避孕药和纯黄体素避孕药。由于更好的功效和可用性，复方荷尔蒙避孕药的需求量很大。分销管道包括妇科中心、门诊手术中心、医院、诊所和家庭护理。

市场动态

人们对荷尔蒙避孕药的使用和益处的认识不断提高，特别是在新兴经济体，以及意外怀孕发生率的增加是全球荷尔蒙避孕药市场成长的关键驱动力。促进其市场成长的其他因素包括不稳定的人际关係、女性选择优先考虑自己的职业、月经人口数量的增加以及控制人口增长的需要。此外，公司之间的合作伙伴关係研发以开发功效更好的荷尔蒙避孕药，以及与性健康相关的政府意识计划可能会推动市场成长。然而，荷尔蒙避孕药的副作用、无荷尔蒙避孕药的可用性、对生物製剂的偏好以及缺乏社会接受度正在限制荷尔蒙避孕药市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球荷尔蒙避孕药市场的每个细分市场进行了包容性评估。荷尔蒙避孕药产业的成长和趋势为本研究提供了整体方法。

市场区隔

荷尔蒙避孕药市场报告的这一部分提供了国家和区域层面的细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

依方法

丸
子宫内避孕器 (IUD)
可注射
阴道环
注入
修补

透过荷尔蒙

复方荷尔蒙避孕药
仅孕激素

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲荷尔蒙避孕药市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。荷尔蒙避孕药市场的主要参与者包括艾伯维公司、Afaxys公司、梯瓦製药工业有限公司、拜耳公司、默克公司、欧加农集团公司、辉瑞公司、Agile Therapeutics、杨森製药公司、羽扇豆製药公司Inc.、Pregna International Ltd. 本部分包含竞争格局的整体视图，其中包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布以及其他事态发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 8 章：荷尔蒙避孕药公司的竞争格局

荷尔蒙避孕药市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 9 章：公司简介

顶级公司市占率分析
市场集中度
Abbvie Inc.

公司概况
公司收入
产品
最新动态

Afaxys Inc.

公司概况
公司收入
产品
最新动态

Teva Pharmaceuticals Industries Ltd.

公司概况
公司收入
产品
最新动态

Bayer AG

公司概况
公司收入
产品
最新动态

Merck & Co. Inc.

公司概况
公司收入
产品
最新动态

Organon Group Of Companies

公司概况
公司收入
产品
最新动态

Pfizer

公司概况
公司收入
产品
最新动态

Agile Therapeutics

公司概况
公司收入
产品
最新动态

Janssen Pharmaceuticals Inc.

公司概况
公司收入
产品
最新动态

Lupin Pharmaceuticals Inc.

公司概况
公司收入
产品
最新动态

Pregna International Ltd

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11215136

The global demand for Hormonal Contraceptives Market is presumed to reach the market size of nearly USD 35.85 Billion by 2032 from USD 23.35 Billion in 2023 with a CAGR of 4.88% under the study period 2024-2032.

Hormonal contraceptives are common methods of birth control. It contains man-made estrogen and progesterone in small amounts. The main purpose of hormonal contraceptives is to disrupt normal hormone balance, suppress ovulation and prevent pregnancy. Hormonal contraceptives come in various forms, namely vaginal ring, hormone-releasing contraceptive coils, skin patches and birth control pill. It is also used to manage polycystic ovary syndrome (PCOS) and is safe and reliable. Hormonal contraceptives are categorized as combination hormonal contraceptives and progestin-only contraceptives. Combined hormonal contraceptives are high in demand due to better efficacy and availability. Distribution channels include gynecology centers, ambulatory surgical centers, hospitals, clinics, and home care.

MARKET DYNAMICS

Increasing awareness related to the use and benefits of hormonal contraceptives, especially in emerging economies, and increasing incidence of unwanted pregnancies are acting as key drivers for global hormonal contraceptive market growth. Other factors that contribute to its market growth are unstable relationships, women opting to prioritize their careers, the increasing number of menstruating population, and the need for controlling population growth. Furthermore, partnerships between companies for R&D to develop hormonal contraceptives with better efficacy and government awareness programs related to sexual health are likely to fuel market growth. However, the side effects of hormonal contraceptives, availability of hormone-free contraceptives, preference for biologics, and lack of social acceptability are restraining hormonal contraceptive market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Hormonal Contraceptives. The growth and trends of Hormonal Contraceptives industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Hormonal Contraceptives market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Method

Pill
Intrauterine Device (IUD)
Injectable
Vaginal Ring
Implant
Patch

By Hormone

Combination Hormonal Contraceptives
Progestin Only

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Hormonal Contraceptives market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Hormonal Contraceptives market include Abbvie Inc., Afaxys Inc., Teva Pharmaceuticals Industries Ltd., Bayer AG, Merck & Co. Inc., Organon Group Of Companies, Pfizer, Agile Therapeutics, Janssen Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., Pregna International Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. HORMONAL CONTRACEPTIVES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Method
- 3.7.2 Market Attractiveness Analysis By Hormone
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL HORMONAL CONTRACEPTIVES MARKET ANALYSIS BY METHOD

5.1. Overview By Method
5.2. Historical and Forecast Data
5.3. Analysis By Method
5.4. Pill Historic and Forecast Sales By Regions
5.5. Intrauterine Device (IUD) Historic and Forecast Sales By Regions
5.6. Injectable Historic and Forecast Sales By Regions
5.7. Vaginal Ring Historic and Forecast Sales By Regions
5.8. Implant Historic and Forecast Sales By Regions
5.9. Patch Historic and Forecast Sales By Regions

6. GLOBAL HORMONAL CONTRACEPTIVES MARKET ANALYSIS BY HORMONE

6.1. Overview By Hormone
6.2. Historical and Forecast Data
6.3. Analysis By Hormone
6.4. Combination Hormonal Contraceptives Historic and Forecast Sales By Regions
6.5. Progestin Only Historic and Forecast Sales By Regions

7. GLOBAL HORMONAL CONTRACEPTIVES MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE HORMONAL CONTRACEPTIVES COMPANIES

8.1. Hormonal Contraceptives Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF HORMONAL CONTRACEPTIVES INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Abbvie Inc.
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Afaxys Inc.
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Teva Pharmaceuticals Industries Ltd.
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Bayer AG
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Merck & Co. Inc.
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Organon Group Of Companies
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Pfizer
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Agile Therapeutics
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Janssen Pharmaceuticals Inc.
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Lupin Pharmaceuticals Inc.
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments
9.13. Pregna International Ltd
- 9.13.1 Company Overview
- 9.13.2 Company Revenue
- 9.13.3 Products
- 9.13.4 Recent Developments